My clinical and research interests include interventional cardiology and high-risk supported percutaneous coronary intervention treatment of patients with advanced and/or complex coronary disease improving patient care through the use of guidelines-based therapies and adherence and prevention of coronary disease. My research has focused on ST-elevation myocardial infarction and reperfusion therapy (restoring blood flow through blocked arteries) and antiplatelet and antithrombotic therapies. I serve on the ACC/AHA oversight committee for guidelines development and have served on the steering committees for several clinical trials on ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes. I am a consultant to the National Institutes of Health (NIH) and a member of the FDA Advisory Panel for Cardiovascular Devices. My published works include over 450 peer-reviewed papers and three books in cardiovascular medicine. I serve on the editorial board for several cardiovascular medicine journals. I am a Fellow of the Royal College of Physicians in Ireland Fellow of the European Society of Cardiology and Fellow of the American College of Cardiology.
Dr. Erik Ohman, MD is an interventional cardiology doctor who practices in Durham, NC. He is 61 years old and has been practicing for 36 years. Dr. Ohman is affiliated with Duke University Hospital.